. The company’s pipeline incorporates 4 scientific-stage therapies. Its most advanced drug prospect is ROS1 inhibitor taletrectinib for treating lung cancer. Nuvation is completing two period 2 pivotal studies on taletrectinib.Even penny stock corporations that are certainly not outright frauds may well have very little monetary information avail